Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06611579

A Clinical Study of the inQB8 Transcatheter Tricuspid Valve Replacement System

Led by inQB8 Medical Technologies, LLC · Updated on 2026-05-18

50

Participants Needed

8

Research Sites

156 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the safety and performance of the inQB8 MonarQ Transcatheter Tricuspid Valve Replacement System in adults with tricuspid valve regurgitation. This multi-center, prospective, single-arm study focuses on participants who have severe or greater symptomatic tricuspid regurgitation and are hemodynamically stable, with adequately treated heart failure according to medical standards. Participants will receive treatment with the inQB8 MonarQ Tricuspid Valve Replacement System, which replaces the tricuspid valve using a transcatheter approach. The study does not include a comparison group and involves only the investigational device intervention. The treatment is delivered through a minimally invasive procedure designed to address the valve condition. During the study, participants will be monitored for major adverse events related to the device or procedure within 30 days, and changes in tricuspid regurgitation grade from baseline will be assessed at 30 days. Secondary measures include device and procedure-related complications, heart function classification, walking ability, health status, repeat assessments of valve regurgitation, and hospitalization rates, which will be evaluated at multiple time points up to about one year on average. Safety and performance data will be collected throughout the study period.

CONDITIONS

Brief Title

Clinical Study of the inQB8 TTVR System (The MonarQ Study)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Anatomically suitable for the MonarQ TTVR System
  • Symptomatic, tricuspid regurgitation that is severe or greater
  • Adequately treated for heart failure based upon medical standards
  • Hemodynamically stable
  • Age 18 years or older
Not Eligible

You will not qualify if you...

  • Need for emergent or urgent surgery for any reason
  • Any planned cardiac surgery within the next 12 months (365 days)
  • Any planned percutaneous cardiac procedure within the next 90 days
  • Refractory heart failure requiring or having required advanced intervention
  • Any condition making it unlikely the patient will complete all protocol procedures and follow-up
  • Currently participating in another investigational biologic, drug, or device study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - 1 day

Participants undergo replacement of the tricuspid valve using the inQB8 MonarQ Transcatheter Tricuspid Valve Replacement System.

1 procedure visit (in-person)

Post-operative Follow-up

Duration - Up to 12 months

Participants are monitored for safety, device performance, and functional outcomes after the valve replacement procedure.

Visits at 30 days, 6 months, and 1 year post-procedure

Trial Site Locations

Total: 8 locations

1

Cedars-Sinai Medical Center

Los Angeles, California, United States, 90048

Actively Recruiting

2

Los Robles Hosptial and Medical Center

Thousand Oaks, California, United States, 91360

Actively Recruiting

3

Piedmont Atlanta Hospital

Atlanta, Georgia, United States, 30309

Actively Recruiting

4

North Shore University Hospital

Manhasset, New York, United States, 11030

Actively Recruiting

5

Penn Presbyterian Medical Center

Philadelphia, Pennsylvania, United States, 19104

Actively Recruiting

6

Baylor Heart Hospital

Plano, Texas, United States, 75093

Actively Recruiting

7

AZ Sint-Jan Brugge AV

Bruges, Belgium, 8000

Actively Recruiting

8

St. Michael's Hospital

Toronto, Ontario, Canada, M5B1W8

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Similar Trials

Cohort Observing Mechanisms, Progression and Sequelae of Val...

Heart Valve Disease

Actively Recruiting

15 locations

Prospective Study of Lead-associated Tricuspid Regurgitation...

Tricuspid Valve Regurgitation

Actively Recruiting

1 location

Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Re...

Tricuspid Valve Regurgitation

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here